What is Plus Therapeutics Inc?
, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 26.64M, and a P/E ratio of 0.2x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.